Purdue Pharma LP – Company Profile & SWOT Analysis

Purdue Pharma LP – Company Profile & SWOT Analysis, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actions, providing a 360Ëš view of the company.

Purdue Pharma LP (Purdue), a subsidiary of MundiPharma International Limited is a pharmaceutical company which develops pharmacologic therapies for the treatment and management of pain. The company undertakes the research, development, manufacture and marketing of prescription medicines and over-the-counter (OTC) medicines and related healthcare products. Its major product categories include prescription opioids, sedatives (for sleep disorders), laxatives, antiseptics and dietary supplements. The company also conducts clinical studies on new investigational drugs and pharmaceuticals on the market. The company operates facilities in North Carolina and New Jersey. Purdue is headquartered in Stamford, Connecticut, the US.

Scope

Detailed information on Purdue Pharma LP required for business and competitor intelligence needs

A study of the major internal and external factors affecting Purdue Pharma LP in the form of a SWOT analysis

An in-depth view of the business model of Purdue Pharma LP including a breakdown and examination of key business segments

News about Purdue Pharma LP, such as business expansion, restructuring, and contract wins

Large number of easy-to-grasp charts and graphs that present important data and key trends

Reasons to buy

Gain understanding of Purdue Pharma LP and the factors that influence its strategies.

Track strategic initiatives of the company and latest corporate news and actions.

Assess Purdue Pharma LP as a prospective partner, vendor or supplier.

Support sales activities by understanding your customers' businesses better.

Stay up to date on Purdue Pharma LPs business structure, strategy and prospects.

Note: Some sections may be missing if data is unavailable for the company.

Companies mentioned

Pain Therapeutics Inc

Napp Pharmaceuticals Ltd

Morningside Pharmaceuticals Ltd

Lannett Company Inc

Hikma Pharmaceuticals Plc

Table of Contents

Table of Contents

Table of Contents

List of Tables

List of Figures

Section 1 - About the Company

Purdue Pharma LP - Key Facts

Purdue Pharma LP - Key Employees

Purdue Pharma LP - Key Employee Biographies

Purdue Pharma LP - Major Products and Services

Purdue Pharma LP - History

Purdue Pharma LP - Company Statement

Purdue Pharma LP - Locations And Subsidiaries

Head Office

Other Locations & Subsidiaries

Section 2 Company Analysis

Company Overview

Purdue Pharma LP - Business Description

Purdue Pharma LP - Corporate Strategy

Purdue Pharma LP - SWOT Analysis

SWOT Analysis - Overview

Purdue Pharma LP - Strengths

Purdue Pharma LP - Weaknesses

Purdue Pharma LP - Opportunities

Purdue Pharma LP - Threats

Purdue Pharma LP - Key Competitors

Section 3 Company’s Lifesciences Financial Deals and Alliances

Purdue Pharma LP, Pharmaceuticals & Healthcare, Deals By Year, 2013 to YTD 2019

Purdue Pharma LP, Pharmaceuticals & Healthcare, Deals By Type, 2013 to YTD 2019

Purdue Pharma LP, Recent Deals Summary

Section 4 Company’s Recent Developments

Jan 29, 2019: Alivio Therapeutics partners Purdue Pharma on non-opioid pain drug

Sep 06, 2018: Purdue Pharma to Present Data from Three Research Studies at PAINWeek 2018 Annual Conference

Sep 05, 2018: Purdue Pharma L.P. to Fund Harm Reduction Therapeutics, Inc.’s Work to Develop Inexpensive, Over-the-Counter, Life-Saving Naloxone in the United States[Newswire : Healthcare-BW]

Sep 04, 2018: BETADINE - A new treatment option for canadians for oral infections - now available in Canada

Aug 02, 2018: Orland Fire joins 13 municipalities in class action suit to block Opioid addiction

Jul 24, 2018: Purdue Pharma announces leadership changes

Jun 08, 2018: Tenn. Attorney General Seeks to Make State’s Complaint against Purdue Pharma Public

Apr 12, 2018: Purdue Pharma Names Dr. John Renger as Vice President, Head of Research & Development and Regulatory Affairs

Mar 01, 2018: Purdue Pharma L.P. Names Dr. Marcelo Bigal as Chief Medical Officer

Feb 09, 2018: Purdue Pharma Issues Statement on Opioid Promotion

Section 5 Appendix

Methodology

About GlobalData

Contact Us

Disclaimer

List of Tables

List of Tables

Purdue Pharma LP, Key Facts

Purdue Pharma LP, Key Employees

Purdue Pharma LP, Key Employee Biographies

Purdue Pharma LP, Major Products and Services

Purdue Pharma LP, History

Purdue Pharma LP, Other Locations

Purdue Pharma LP, Subsidiaries

Purdue Pharma LP, Key Competitors

Purdue Pharma LP, Pharmaceuticals & Healthcare, Deals By Year, 2013 to YTD 2019

Purdue Pharma LP, Pharmaceuticals & Healthcare, Deals By Type, 2013 to YTD 2019

Purdue Pharma LP, Recent Deals Summary

List of Figures

List of Figures

Purdue Pharma LP, Pharmaceuticals & Healthcare, Deals By Year, 2013 to YTD 2019

Purdue Pharma LP, Pharmaceuticals & Healthcare, Deals by Type, 2013 to YTD 2019

    Pricing

Discounts available for multiple purchases.

reportstore@marketline.com
+44 20 7947 2960

Saved reports